Cargando…
Thorax radiotherapy using (18)F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis
BACKGROUND: This retrospective study compared positron emission tomography (PET)/computed tomography (CT) and CT in the treatment of extracranial oligometastatic non-small-cell lung cancer (NSCLC) and explored the impact of thorax radiotherapy (TRT) on patient survival. METHODS: We reviewed the medi...
Autores principales: | Liu, Cheng-Sen, Song, Ying-Qiu, Wang, Run-Ze, Wang, Zheng, He, Rong, Xu, Ke, Wang, Chen-Yu, Wu, Yu, Wang, Ye, Zhang, Xiao-fang, Li, Guang, Wang, Tian-Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639371/ https://www.ncbi.nlm.nih.gov/pubmed/36353556 http://dx.doi.org/10.3389/fonc.2022.991378 |
Ejemplares similares
-
Treatment patterns and survival after 18F-fluorodeoxyglucose positron emission tomography/computed tomography-guided local consolidation therapy for oligometastatic non-small cell lung cancer: a two-center propensity score-matched analysis
por: Song, Ying-Qiu, et al.
Publicado: (2020) -
Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020) -
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography imaging review of benign lesions of the thorax
por: Ravikanth, Reddy
Publicado: (2020) -
In 18F-positron emission tomography/computed tomography-guided precision radiotherapy for centrally located non-small cell lung cancer, tumor related atelectasis is a prognostic factor of survival
por: Wang, Nan, et al.
Publicado: (2022) -
Dual‐Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy
por: Wurzer, Alexander, et al.
Publicado: (2017)